| Dr Madhu V Midathada, MD | |
|
4004 Pioneer Woods Dr, Lincoln, NE 68506-7548 | |
| (402) 484-4900 | |
| (402) 484-6456 |
| Full Name | Dr Madhu V Midathada |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 32 Years |
| Location | 4004 Pioneer Woods Dr, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265511034 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RX0202X | Internal Medicine - Medical Oncology | 23290 (Nebraska) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 23290 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Bryan Medical Center | Lincoln, NE | Hospital |
| Chi Health St. Elizabeth | Lincoln, NE | Hospital |
| Memorial Health Care Systems | Seward, NE | Hospital |
| Butler County Health Care Center | David city, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nebraska Hematology-oncology Pc | 9638083330 | 19 |
News Archive
With the recognition that certain subgroups of the population seemed to have a higher risk of developing severe disease following infection, some countries put shielding policies into place to protect them from infection.
Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.
"Parents and officials are going to great lengths to immunize children after militants imposed a ban on polio vaccinations in Pakistan's restive North Waziristan Agency," with some parents "traveling long distances to get their children vaccinated" or "smuggling the vaccine back home," IRIN reports.
Ordinarily, embryonic stem cells exist only a day or two as they begin the formation of the embryo itself. Then they are gone. In the laboratory dish, however, they act more like perpetual stem cells - renewing themselves and exhibiting the ability to form cells of almost any type, a status called totipotency.
A new study done with mice has discovered that supplements of lipoic acid can inhibit formation of arterial lesions, lower triglycerides, and reduce blood vessel inflammation and weight gain - all key issues for addressing cardiovascular disease.
› Verified 9 days ago
| Entity Name | Nebraska Hematology-oncology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205915071 PECOS PAC ID: 9638083330 Enrollment ID: O20031117000833 |
News Archive
With the recognition that certain subgroups of the population seemed to have a higher risk of developing severe disease following infection, some countries put shielding policies into place to protect them from infection.
Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.
"Parents and officials are going to great lengths to immunize children after militants imposed a ban on polio vaccinations in Pakistan's restive North Waziristan Agency," with some parents "traveling long distances to get their children vaccinated" or "smuggling the vaccine back home," IRIN reports.
Ordinarily, embryonic stem cells exist only a day or two as they begin the formation of the embryo itself. Then they are gone. In the laboratory dish, however, they act more like perpetual stem cells - renewing themselves and exhibiting the ability to form cells of almost any type, a status called totipotency.
A new study done with mice has discovered that supplements of lipoic acid can inhibit formation of arterial lesions, lower triglycerides, and reduce blood vessel inflammation and weight gain - all key issues for addressing cardiovascular disease.
› Verified 9 days ago
| Entity Name | Nemaha County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437767860 PECOS PAC ID: 6204746480 Enrollment ID: O20200811000288 |
News Archive
With the recognition that certain subgroups of the population seemed to have a higher risk of developing severe disease following infection, some countries put shielding policies into place to protect them from infection.
Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.
"Parents and officials are going to great lengths to immunize children after militants imposed a ban on polio vaccinations in Pakistan's restive North Waziristan Agency," with some parents "traveling long distances to get their children vaccinated" or "smuggling the vaccine back home," IRIN reports.
Ordinarily, embryonic stem cells exist only a day or two as they begin the formation of the embryo itself. Then they are gone. In the laboratory dish, however, they act more like perpetual stem cells - renewing themselves and exhibiting the ability to form cells of almost any type, a status called totipotency.
A new study done with mice has discovered that supplements of lipoic acid can inhibit formation of arterial lesions, lower triglycerides, and reduce blood vessel inflammation and weight gain - all key issues for addressing cardiovascular disease.
› Verified 9 days ago
| Entity Name | Chi Health Clinic Specialty Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285138065 PECOS PAC ID: 4789098443 Enrollment ID: O20210121000492 |
News Archive
With the recognition that certain subgroups of the population seemed to have a higher risk of developing severe disease following infection, some countries put shielding policies into place to protect them from infection.
Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.
"Parents and officials are going to great lengths to immunize children after militants imposed a ban on polio vaccinations in Pakistan's restive North Waziristan Agency," with some parents "traveling long distances to get their children vaccinated" or "smuggling the vaccine back home," IRIN reports.
Ordinarily, embryonic stem cells exist only a day or two as they begin the formation of the embryo itself. Then they are gone. In the laboratory dish, however, they act more like perpetual stem cells - renewing themselves and exhibiting the ability to form cells of almost any type, a status called totipotency.
A new study done with mice has discovered that supplements of lipoic acid can inhibit formation of arterial lesions, lower triglycerides, and reduce blood vessel inflammation and weight gain - all key issues for addressing cardiovascular disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Madhu V Midathada, MD 4004 Pioneer Woods Dr, Lincoln, NE 68506-7548 Ph: (402) 484-4900 | Dr Madhu V Midathada, MD 4004 Pioneer Woods Dr, Lincoln, NE 68506-7548 Ph: (402) 484-4900 |
News Archive
With the recognition that certain subgroups of the population seemed to have a higher risk of developing severe disease following infection, some countries put shielding policies into place to protect them from infection.
Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.
"Parents and officials are going to great lengths to immunize children after militants imposed a ban on polio vaccinations in Pakistan's restive North Waziristan Agency," with some parents "traveling long distances to get their children vaccinated" or "smuggling the vaccine back home," IRIN reports.
Ordinarily, embryonic stem cells exist only a day or two as they begin the formation of the embryo itself. Then they are gone. In the laboratory dish, however, they act more like perpetual stem cells - renewing themselves and exhibiting the ability to form cells of almost any type, a status called totipotency.
A new study done with mice has discovered that supplements of lipoic acid can inhibit formation of arterial lesions, lower triglycerides, and reduce blood vessel inflammation and weight gain - all key issues for addressing cardiovascular disease.
› Verified 9 days ago
Ted M Triggs, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-219-8747 Fax: 402-219-8748 | |
Joseph L Kummer, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1600 S 48th St, Suite 600, Lincoln, NE 68506 Phone: 402-483-3333 Fax: 402-483-3297 | |
Brenda Kay Bell, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1919 S 40th, Ste 207, Lincoln, NE 68506 Phone: 402-489-3383 Fax: 402-489-3789 | |
Scott Allen Heasty, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-481-4780 Fax: 402-481-5377 | |
Scott Charles Rasmussen, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3901 Pine Lake Rd, Suite 220, Lincoln, NE 68516 Phone: 402-421-3240 Fax: 402-423-0739 | |
Jeffrey E Jarrett, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1500 S 48th St, Suite 800, Lincoln, NE 68506 Phone: 402-483-8600 Fax: 402-483-8689 | |
Tracy L Slocum Farritor, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-219-8747 Fax: 402-219-8748 |